跳至主要内容
临床试验/NCT05223010
NCT05223010已完成4 期

Evaluation of Preoperative Melatonin on Emergence Agitation After Herniorrhaphy Surgeries in Pediatrics

Menoufia University1 个研究点 分布在 1 个国家目标入组 117 人开始时间: 2022年1月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
117
试验地点
1
主要终点
emergence behaviour

研究概览

简要总结

efficacy of melatonin premedication on emergence agitation in children undergoing herniorrhaphy surgeries

详细描述

Before administration of the oral premedication, each patient's baseline heart rate, mean systemic arterial pressure, pulse oximetry, and sedation score (yale preoperative score) will be recorded All the anesthetic and surgical techniques will be standardized. On arrival at the operating room, continuous electrocardiogram, non-invasive blood pressure and pulse oximetry monitors will be applied. Baseline readings of all the parameters will be recorded.

Sevoflurane 3-8 MAC will be used for induction of anaesthesia. While intravenous line is inserted, atropine 0.01 mg/kg, atracurium 0.0.05 mg/kg is given. Anaesthesia maintainance done by 1.5-2 MAC sevoflurane. At the end of operation discontinuation of inhalational anesthesia will be done and muscle relaxant will be reversed by neostigmine 0.05 mg/kg and atropine 0.02 mg/kg. Then children were transferred to recovery till complete recovery Parameters assessed are induction time (IT) time from the start of sevoflurane inhalation to the start of endtracheal tube insertion, duration of anesthesia (DA) time from the start of sevoflurane inhalation to discontinuation of sevoflurane inhalation, time up to spontaneous eye opening (time from removal of endotracheal tube till spontaneous eye opening), duration of stay in recovery and any side effects

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
4 Years 至 8 Years(Child)
性别
All
接受健康志愿者

入选标准

  • scheduled for unilateral inguinal herniorrhaphy
  • parents conscent

排除标准

  • allergy to this study drug
  • Patients with a history of cardiovascular, psychiatric, neurological, endocrine, chest disease, and/or severe renal or hepatic dysfunction

研究组 & 干预措施

2

Active Comparator

39 participant will receive melatonin 0.2 mg/kg

干预措施: Sevoflurane (Drug)

1

Active Comparator

39 participant will receive melatonin 0.05 mg/kg

干预措施: Melatonin 5 MG/15 ML Oral Solution 0.05 mg/kg (Drug)

1

Active Comparator

39 participant will receive melatonin 0.05 mg/kg

干预措施: Sevoflurane (Drug)

2

Active Comparator

39 participant will receive melatonin 0.2 mg/kg

干预措施: Melatonin 5 MG/15 ML Oral Solution 0.2mg/kg (Drug)

3

Active Comparator

39 participant will receive melatonin 0.4 mg/kg

干预措施: Melatonin 5 MG/15 ML Oral Solution 0.4mg/kg (Drug)

3

Active Comparator

39 participant will receive melatonin 0.4 mg/kg

干预措施: Sevoflurane (Drug)

结局指标

主要结局

emergence behaviour

时间窗: 5 min, 15 min and 30 min after arrival to recovery

change from baseline on a 5 point scale

次要结局

  • yale preoperative anxiety scale(before administration of oral premedication and before anaesthesia induction)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

mostafa saieed fahim mansour

lecturer

Menoufia University

研究点 (1)

Loading locations...

相似试验